Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03833817 · ClinicalTrials.gov registry record · NA
Patient-caregiver Communication Intervention for Prognostic Understanding
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03833817 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 28 participants.
The verdict
NCT03833817, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to: (1) develop a communication-based intervention to improve advanced cancer patients' and caregivers' prognostic understanding using communication strategies (e.g., acknowledgment, validation of fears) and distress management techniques (e.g., deep breathing, muscle relaxation); (2) evaluate the feasibility and acceptability of the intervention among advanced cancer patients and their caregivers; and (3) test the preliminary efficacy of the intervention on patients' and caregivers' prognostic understanding (primary outcome); completion of DNR order, living will, and health care proxy; psychological distress; communication quality; caregiver burden; and healthcare utilization (secondary outcomes).
Interventions
- BEHAVIORAL Talking about Cancer (TAC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-09-20 |
| Est. Completion | 2022-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03833817
The ClinicalTrials.gov registry entry for NCT03833817 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Talking about Cancer (TAC) is the first listed.
NCT03833817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03833817 about?
NCT03833817 is a clinical study titled "Patient-caregiver Communication Intervention for Prognostic Understanding". The purpose of this study is to: (1) develop a communication-based intervention to improve advanced cancer patients' and caregivers' prognostic understanding using communication strategies (e.g., acknowledgment, validation of fears) and distress management techniques (e.g., deep breathing, muscle re...
What is the current status of trial NCT03833817?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2020-09-20. Estimated completion is 2022-01-18.
What interventions are being tested in trial NCT03833817?
The interventions under investigation include: Talking about Cancer (TAC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03833817?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.